Copyright
©The Author(s) 2017.
World J Gastroenterol. May 14, 2017; 23(18): 3322-3329
Published online May 14, 2017. doi: 10.3748/wjg.v23.i18.3322
Published online May 14, 2017. doi: 10.3748/wjg.v23.i18.3322
Table 1 Descriptive information regarding the dataset (n = 99)
Characteristic | n (%) |
Gender | |
Male | 47 (47) |
Female | 52 (53) |
Ulcerative colitis (UC) duration - scope | |
New onset | 1 (1) |
< 1 yr | 16 (16) |
1-3 yr | 30 (30) |
3-5 yr | 16 (16) |
> 5 yr | 36 (36) |
Indication for procedure | |
Suspicion of UC | 1 (1) |
Active symptoms | 61 (62) |
Consideration of Medication change | 10 (10) |
Assessment of Medication efficacy | 13 (14) |
Cancer screening | 14 (14) |
Paris classification | |
E1 Proctitis | 1 (1) |
E2 Left-sided | 20 (20) |
E3 Extensive | 5 (5) |
E4 Pancolitis | 73 (74) |
Medications at time of colonoscopy | |
5-aminosalicylic acid (5 ASA) | 67 (68) |
Steroids | 30 (30) |
Mercaptopurine/methotrexate | 33 (33) |
Infliximab/adalimumab | 12 (12) |
Antibiotics | 10 (10) |
Five ASA Enema | 5 (5) |
Hydrocortisone Enema | 10 (10) |
Methotrexate | 1 (1) |
Tacrolimus | 3 (3) |
VSL 3 probiotic | 10 (10) |
Table 2 Inter-observer agreement in grading rectal disease severity (Mayo scores) between reviewers
Reviewer AB | Reviewer PR | |||||
0 | 1 | 2 | 3 | Unknown | Total | |
0 | 22 | 4 | 1 | 0 | 0 | 27 |
1 | 1 | 22 | 12 | 1 | 0 | 36 |
2 | 0 | 2 | 8 | 4 | 0 | 14 |
3 | 0 | 0 | 1 | 3 | 0 | 4 |
Unknown | 0 | 0 | 0 | 0 | 18 | 18 |
Total | 23 | 28 | 22 | 8 | 18 | 99 |
Table 3 Inter-observer agreement in grading sigmoid disease severity (Mayo score) between reviewers
Reviewer AB | Reviewer PR | |||||
0 | 1 | 2 | 3 | Unknown | Total | |
0 | 22 | 5 | 0 | 0 | 0 | 27 |
1 | 2 | 22 | 12 | 4 | 0 | 40 |
2 | 0 | 3 | 9 | 7 | 0 | 19 |
3 | 0 | 0 | 5 | 3 | 0 | 8 |
Unknown | 0 | 0 | 0 | 0 | 5 | 5 |
Total | 24 | 30 | 26 | 14 | 5 | 99 |
Table 4 Pediatric ulcerative colitis activity index data by component
Characteristic | mean ± SD or n (%) |
Age at time of colonoscopy (yr) | 15.7 (4.1) |
Days between colonoscopy and PUCAI score | 14.8 (10.6) |
Method of PUCAI collection | |
Prospectively entered at time of clinic visit | 27 (27) |
Calculated from medical record | 72 (73) |
Abdominal pain | |
No pain | 52 (53) |
Present but ignored | 36 (36) |
Cannot be ignored | 11 (11) |
Rectal bleeding | |
None | 49 (49) |
Small amount, < 50% | 20 (20) |
Small amount, most | 27 (27) |
Large amount | 3 (3) |
Consistency | |
Formed | 57 (58) |
Partially formed | 35 (35) |
Completely unformed | 7 (7) |
Number of stools | |
0-2 | 61 (62) |
3-5 | 21 (21) |
6-8 | 11 (11) |
> 8 | 6 (6) |
Nocturnal stools | 18 (18) |
Activity limitation | |
No limitation | 62 (63) |
Occasional limitation | 29 (29) |
Severe restriction | 8 (8) |
Overall activity | |
Remission, 0-9 | 33 (33) |
Mild, 10-34 | 39 (39) |
Moderate, 35-64 | 23 (23) |
Severe, > 64 | 4 (4) |
- Citation: Kerur B, Litman HJ, Stern JB, Weber S, Lightdale JR, Rufo PA, Bousvaros A. Correlation of endoscopic disease severity with pediatric ulcerative colitis activity index score in children and young adults with ulcerative colitis. World J Gastroenterol 2017; 23(18): 3322-3329
- URL: https://www.wjgnet.com/1007-9327/full/v23/i18/3322.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i18.3322